Enrofloxacin Hcl 112732-17-9 Enrofloxacin Hcl supplier
1. Basic information
Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine
Appearance: Light-yellow or light-yellow orange crystalline powder
Purity: 99% min
2.Introduction
Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
3.Specification
Item |
Standard |
Result |
Appearance |
Light-yellow or light-yellow orange crystalline powder |
Light-yellow crystalline Powder |
Melting range |
Between 221°C and 226°C |
223.0°C~225.5°C |
Identification |
Meet the requirements |
Meet the requirements |
Fluoroquinolonic acid |
Not more than 0.2% |
<0.2% |
Ciprofloxacin |
Not more than 1.0% |
0.15% |
Loss on drying |
Not more than 3.0% |
0.1% |
Residue on ignition |
Not more than 0.2% |
0.04% |
Heavy metals |
Not more than 20ppm |
<20ppm |
Assay(on the dried basis) |
Not less than 98.5% |
99.1% |
4.Application
Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
1. Basic information
Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine
Appearance: Light-yellow or light-yellow orange crystalline powder
Purity: 99% min
2.Introduction
Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.
3.Specification
Item |
Standard |
Result |
Appearance |
Light-yellow or light-yellow orange crystalline powder |
Light-yellow crystalline Powder |
Melting range |
Between 221°C and 226°C |
223.0°C~225.5°C |
Identification |
Meet the requirements |
Meet the requirements |
Fluoroquinolonic acid |
Not more than 0.2% |
<0.2% |
Ciprofloxacin |
Not more than 1.0% |
0.15% |
Loss on drying |
Not more than 3.0% |
0.1% |
Residue on ignition |
Not more than 0.2% |
0.04% |
Heavy metals |
Not more than 20ppm |
<20ppm |
Assay(on the dried basis) |
Not less than 98.5% |
99.1% |
4.Application
Dogs and Cats
The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
Pigs
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.
CAS NO:9005-65-6
CAS NO:1338-43-8
CAS NO:133-37-9
CAS NO:149-32-6
CAS NO:128-37-0
CAS NO:149-91-7
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View